Tony Teramana Cancer Center Med is categorized under Oncologists in Steubenville, OH and active since 2010.
Tony Teramana Cancer Center Med was established in 2010, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6223100 by the NAICS.
If you are seeking more information, feel free to contact Lynn Barbe, Manager at the company’s single location by writing to 3204 Johnson Road, Steubenville, Ohio OH 43952 or by phoning (740) 264-8700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Tony Teramana Cancer Center Med |
Contact Person: | Lynn Barbe, Manager |
Address: | 3204 Johnson Road, Steubenville, Ohio 43952 |
Phone Number: | (740) 264-8700 |
Website Address: | trinityhealth.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Oncologists |
SIC Code: | 8011 |
NAICS Code: | 6223100 |
Share This Business: |
Tony Teramana Cancer Center Med was started in 2010 to provide professional Oncologists under the SIC code 8011 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Lynn Barbe, Manager for inquiries that concern Tony Teramana Cancer Center Med by calling the company number (740) 264-8700, as your correspondence is most welcome. Additionally, the physical location of the single location of Tony Teramana Cancer Center Med can be found at the coordinates 40.36907,-80.65964 as well as the street address 3204 Johnson Road in Steubenville, Ohio 43952.
For its online presence, you may visit Tony Teramana Cancer Center Med’s website at trinityhealth.com and engage with its social media outlets through on Twitter and on Facebook.